Propanc Biopharma appoints Jeannine Zimmerman as CFO effective Aug 13, 2025

Propanc Biopharma, Inc.

Jeannine Zimmerman, age 48, appointed CFO effective August 13, 2025.
She holds a B.S. in accounting from St. Joseph's College; experience includes SEC filings, audit, and SOX 404 testing.
Prior to appointment, CEO James Nathanielsz had served as both CEO and CFO.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.